2012598-51-3
2012598-51-3
Chemical Structure
Oltipraz-d3
Synonym(s): RP 35972-d3;NSC 347901-d3
- CAS No.: 2012598-51-3
- Formula:C8H3D3N2S3
- Molecular Weight:229.36
IUPAC Name: 4-(methyl-d3)-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione
InChIKey: CKNAQFVBEHDJQV-FIBGUPNXSA-N
SMILES: S=C1SSC(C2=NC=CN=C2)=C1C([2H])([2H])[2H]
Biological Activity: Oltipraz-d3 is the deuterium labeled Oltipraz. Oltipraz has an inhibitory effect on HIF-1α activation in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM. Oltipraz is a potent Nrf2 activator.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oltipraz-d3 | Oltipraz-d3 is the deuterium labeled Oltipraz. Oltipraz has an inhibitory effect on HIF-1α activation in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM. Oltipraz is a potent Nrf2 activator. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oltipraz (Standard) | ≥98% | Oltipraz (Standard) is the analytical standard of Oltipraz. This product is intended for research and analytical applications. Oltipraz has an inhibitory effect on HIF-1α activation in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM. Oltipraz is a potent Nrf2 activator. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oltipraz | 99.87% | Oltipraz has an inhibitory effect on HIF-1α activation in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM. Oltipraz is a potent Nrf2 activator. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oltipraz (GMP) | Oltipraz (GMP) is Oltipraz (HY-12519) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Oltipraz has an inhibitory effect on HIF-1α activation. Oltipraz is a potent Nrf2 activator. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
